Esomeprazole for Treatment of GERD in Pediatric Patients
NCT00228527
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux Disease (GERD)
Erosive Esophagitis
Non-erosive Esophagitis
Interventions
DRUG:
Esomeprazole (Nexium)
Sponsor
AstraZeneca